Literature DB >> 8578446

Thrombin generation in plasma: its assessment via the endogenous thrombin potential.

H C Hemker1, S Béguin.   

Abstract

Thrombin generation is a pivotal function of plasma in haemostasis and thrombosis. Its mechanism is essentially the classical cascade, the velocity of which is governed by the availability of factors Va and VIIIa and that is confined to the surface of the procoagulant membranes which appear at the site of injury. There is no routine test that quantitatively renders the thrombin forming capacity of a plasma sample. Clotting times (PT-prothrombin time, APTT-activated partial tromboplastin time) do not reflect the over all thrombin generation and are insensitive to hypercoagulative states. The endogenous thrombin potential (ETP), i.e. the area under the thrombin generation curve, better represents this function. We developed a method to assess the ETP in the routine laboratory. The first results suggest that it is a sensitive indicator for every form of anticoagulation. It is increased in hypercoagulable states thus far studied, both congenital and acquired and can be designed to indicate deficiencies in protein C and S and APC (activated protein C) resistance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578446

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  29 in total

1.  Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography.

Authors:  G E Rivard; K E Brummel-Ziedins; K G Mann; L Fan; A Hofer; E Cohen
Journal:  J Thromb Haemost       Date:  2005-09       Impact factor: 5.824

2.  F9 Malmö, factor IX and deep vein thrombosis.

Authors:  Irene D Bezemer; Andre R Arellano; Carmen H Tong; Charles M Rowland; Helen A Ireland; Kenneth A Bauer; Joseph Catanese; Pieter H Reitsma; Carine J M Doggen; James J Devlin; Frits R Rosendaal; Lance A Bare
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

3.  In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices.

Authors:  Gaurav Girdhar; Junwei Li; Larisa Kostousov; John Wainwright; Wayne L Chandler
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

4.  Thrombogenicity of the p48 and anti-thrombogenic p48 hydrophilic polymer coating low-profile flow diverters in an in vitro human thrombin generation model.

Authors:  Pervinder Bhogal; Tim Lenz-Habijan; Catrin Bannewitz; Ralf Hannes; Hermann Monstadt; Martin Brodde; Beate Kehrel; Hans Henkes
Journal:  Interv Neuroradiol       Date:  2020-05-04       Impact factor: 1.610

5.  Endurance training modifies exercise-induced activation of blood coagulation: RCT.

Authors:  Thomas Hilberg; Kathleen Menzel; Udo F Wehmeier
Journal:  Eur J Appl Physiol       Date:  2012-12-13       Impact factor: 3.078

6.  Factor VIII lacking the C2 domain retains cofactor activity in vitro.

Authors:  Hironao Wakabayashi; Amy E Griffiths; Philip J Fay
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

7.  Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.

Authors:  M Monaghan; H Wakabayashi; A E Griffiths; P J Fay
Journal:  J Thromb Haemost       Date:  2016-03-21       Impact factor: 5.824

8.  Sequences flanking Arg336 in factor VIIIa modulate factor Xa-catalyzed cleavage rates at this site and cofactor function.

Authors:  Jennifer P DeAngelis; Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2012-03-12       Impact factor: 5.157

9.  Thrombin activity propagates in space during blood coagulation as an excitation wave.

Authors:  N M Dashkevich; M V Ovanesov; A N Balandina; S S Karamzin; P I Shestakov; N P Soshitova; A A Tokarev; M A Panteleev; F I Ataullakhanov
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

10.  Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth?

Authors:  S Koutroumpi; L Spiezia; N Albiger; M Barbot; M Bon; S Maggiolo; S Gavasso; P Simioni; A Frigo; F Mantero; C Scaroni
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.